Point of Care Testing for Sexually Transmitted Infections – Where are we now and where do we want to be

 Effective STI control is challenged by inadequate access to prompt diagnosis and treatment for patients and partners, poor community STI surveillance for targeting public health interventions and changing antimicrobial resistance patterns. Novel field-based detection and sequencing technologies for diagnosis and antimicrobial resistance may address these issues by enabling immediate optimised treatment and partner notification, improved capacity to reach those disproportionately affected away from traditional settings of care as well as creating opportunities for monitoring outbreaks. To enable measurable gain from these advances, adaptation of technologies to suit clinical and publichealth purposes in socially contextualized strategies will be necessary. This may ultimately give scope for reducing STI transmission and impacting on disease burden and outcomes.